Pr3vent, Inc., a Palo Alto, California-based healthcare technology company, raised a seed funding round of undisclosed amount.
Skyview Ventures, the early and growth stage investment arm of global private investment firm Skyview Capital, LLC, Phillip Sarofim and his private equity/venture capital firm Trousdale Ventures, LLC (formerly PS Ventures), made the investment.
The company intends to use the funds to accelerate development of its eye screening diagnostic service designed expressly for newborns.
Founded by medical field veterans Jochen Kumm, PhD and Darius M. Moshfeghi, MD., Pr3vent is a healthcare IT company currently developing Artificial Intelligence and Machine Learning screens for ophthalmic newborn conditions. The company’s [patented] algorithms and screening service is being developed for applications in newborn eye screening.